3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sezary Syndrome
1
Sarcoma
1
Paget Disease, Extramammary
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Neurofibroma
1
Mycosis Fungoides
1
Muir-Torre Syndrome
1
Microcystic adnexal carcinoma
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Eccrine Porocarcinoma
1
Carcinoma, Signet Ring Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Basosquamous
1
Carcinoma, Basal Cell
1
Adenocarcinoma, Papillary
1
Interventions
Bevacizumab
56
Cetuximab
50
Fluorouracil
45
Leucovorin
39
Oxaliplatin
38
pembrolizumab
31
Specimen Handling
27
Irinotecan
25
Magnetic Resonance Spectroscopy
17
Biopsy
17
Nivolumab
15
HMPL-013
13
Folfox protocol
13
Capecitabine
13
Gemcitabine
12
Cisplatin
12
trifluridine tipiracil drug combination
11
Panitumumab
11
Carboplatin
11
Pemetrexed
9
IFL protocol
9
encorafenib
8
balstilimab
8
Standard of Care
8
Paclitaxel
8
Early Intervention, Educational
8
130-nm albumin-bound paclitaxel
8
fludarabine
7
atezolizumab
7
Educational Status
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
talimogene laherparepvec
×
90 days
×
Clear all
No trials found.